Sulbactam
379
relevant articles (95 outcomes,
80 trials/studies)
found for this Drug
Description:
A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.
Also Known As:
Bétamaze; CP-45899; Combactam; Penicillanic Acid Sulfone; Pfizer Brand of Sulbactam Sodium; Sulbactam Sodium; CP 45899; CP45899; Sodium, Sulbactam; Sulfone, Penicillanic Acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S-cis)-
Relationship Network
Drug Context: Research Results